InterCure Ltd Investor Relations Material
Latest events
Q4 2022
InterCure Ltd
Q4 2023
1 May, 2024
Q2 2023
31 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from InterCure Ltd
Access all reports
InterCure Ltd is a pharmaceutical company focused on the production and distribution of medical cannabis products. Through its subsidiary, Canndoc, the company cultivates and manufactures pharmaceutical-grade cannabis used for medical treatments. InterCure offers a range of cannabis-based products, including oils, flowers, and other formulations designed for therapeutic purposes. The company partners with international healthcare and cannabis companies to expand its product offerings and distribution channels in global markets where medical cannabis is regulated. The company is headquartered in Herzliya, Israel, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
INCR
Country
🇺🇸 United States